Testing for haemochromatosis in a liver clinic population: Relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 3, 2002, Pages 223-229

  Moodie, Simon J ^a   Ang, Liza ^a   Stenner, Jonathan M C ^a   Finlayson, Caroline ^a   Khotari, Archana ^a   Levin, Gerald E ^a   Maxwell, J Douglas ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

C282Y; Genetic testing; H63D; Haemochromatosis

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE MARKER; ETHNIC GROUP; EUROPE; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDEROSIS; TRANSFERRIN BLOOD LEVEL;

ETHNIC GROUPS; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; TRANSFERRIN;

EID: 0036206229     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200203000-00004     Document Type: Article

References (27)

1. A simple genetic test identifies 90% of UK patients with haemochromatosis
2. The significance of haemochromatosis gene mutations in the general population: Implications for screening
3. Population screening for haemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors
4. Population-based screening for haemochromatosis using phenotypic and DNA testing among employees of health maintenance organisations in Springfield, Missouri
5. A population-based study of the clinical expression of the haemochromatosis gene
6. Expression of HLA linked haemochromatosis in subjects homozygous and heterozygous for the C282Y mutation
7. Genotypic/phenotypic correlations in genetic haemochromatosis: Evolution of diagnostic criteria
8. HFE mutations analysis in 711 haemochromatosis probands: Evidence for S65C implication in mild form of haemochromatosis
9. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
10. Haemochromatosis in Ireland and HFE
11. Celtic origin of the C282Y mutation of haemochromatosis
12. Prevalence of hereditary haemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor?
13. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic haemochromatosis?
14. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany
15. EASL International Consensus Conference on Haemochromatosis
16. Screening for genetic haemochromatosis in blood samples with raised alanine transferase
17. Global prevalence of putative haemochromatosis mutations
18. A common intron 3 mutation (IVS3-48c - g) leads to misdiagnosis of the c.845G - A(C282Y) HFE gene mutation
19. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
20. Expression of haemochromatosis in homozygous subjects. Implications for early diagnosis and prevention
21. Molecular medicine and haemochromatosis: At the crossroads
22. Population screening for haemochromatosis
23. Assay of serum ferritin
24. Non-invasive prediction of fibrosis in C282Y homozygous haemochromatosis
25. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis